Solid-phase synthesis of a 5K-member array of N-[(1,4-cyclicdiaminocarbonyl)phenyl]arylsulfonamide

ORGN 585

Deana F. Wang, deana.f.wang@gsk.com1, Yonghui Wang1, Jian Jin1, Todd L Graybill1, Michael L. Moore1, and Ralph Rivero2. (1) High Throughput Chemistry, Glaxosmithkline, 1250 South Collegeville RD, P.O. Box 5089, UP12-210, Collegeville, PA 19426, (2) GlaxoSmithKline Pharmaceuticals, 1250 S Collegeville Road UP1105, Collegeville, PA 19426

A solid-phase synthesis of N-[(1,4-cyclicdiaminocarbonyl)phenyl] arylsulfonamides using high-loading 2,6-dimethoxy-4-polystyrenebenzyloxy-benzaldehyde (DMHB) resin was developed and successfully applied to the preparation of a 5K-member array with four-points of diversity.  The key step, the monoacylation of unprotected symmetrical cyclic diamines with DMHB-resin bound benzoic acids, was selectively achieved without cross-linking side-reactions.  The synthetic methodology, coupled with using IRORI directed-sorting technology, made the array preparation quite successful.  The design, solid phase chemistry, monomer validation, and results will be described in the poster.